Skip to main content
SpringerLink
Log in

Rifapentine Offers Greater Convenience in the Treatment of Pulmonary Tuberculosis

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zumla A, Grange J. Tuberculosis. BMJ 1998; 316: 1962–4

    Article  PubMed  CAS  Google Scholar 

  2. Pilheu JA. Tuberculosis 2000: problems and solutions. Int J Tuberc Lung Dis 1998; 2: 696–703

    PubMed  CAS  Google Scholar 

  3. Josefson D. FDA approves tuberculosis drug. BMJ 1998; 317: 11

    Article  PubMed  CAS  Google Scholar 

  4. Jarvis B, Lamb HM. Rifapentine. Drugs 1998; 56: 607–16

    Article  CAS  Google Scholar 

  5. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359–74

    Google Scholar 

  6. Hoechst Marion Roussel Inc. Rifapentine. PDR Generics 1998. Montvale, New Jersey, USA: Medical Economics: 1334

    Google Scholar 

  7. Hoechst Marion Roussel Inc. Rifampin. PDR Generics 1998. Montvale, New Jersey, USA: Medical Economics: 1341

    Google Scholar 

  8. British National Formulary. No. 36. London: The Pharmaceutical Press, 1998 Sep

  9. Vernon A, Khan A, Bozeman L, et al. Update on US public health service (USPHS) study 22: a trial of once weekly isoniazid (INH) & rifapentine (RPT) in the continuation phase of TB treatment [abstract]. Am J Respir Crit Care Med 1998; 157 (3 Pt 2): A467

    Google Scholar 

  10. Tam CM, Chan SL, Lam CW, et al. Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. Int J Tuberc Lung Dis 1997; 1: 411–6

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rifapentine Offers Greater Convenience in the Treatment of Pulmonary Tuberculosis. Drugs Ther. Perspect 13, 1–4 (1999). https://doi.org/10.2165/00042310-199913070-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199913070-00001

Keywords

Search

Navigation